Drug firm Torrent Pharmaceuticals has launched in India its biosimilar Adalimumab, used for the treatment of auto immune disorders, under the brand name ^Adfrar^. The company^s product will be available as pre-filled syringe of 40 mg, Torrent Pharmaceuticals said in a statement. It, however, did not give any details about the price at which the biosimilar will be available.

http://www.business-standard.com/article/pti-stories/torrent-pharma-launches-adalimumab-biosimilar-in-india-116011200437_1.html

About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *